American Vanguard Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
FY EPS (est.)
-$0.13next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 10 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Net Sales Quarterly124MTarget: 530000000 to 550000000
Adjusted EBITDA Quarterly10.3MTarget: 44000000 to 48000000
Gross Profit Margin Quarterly31.0%Target: Near-term double-digit area, long-term 15% EBITDA margin
Watch Items
- U.S. Crop Sales GrowthTrigger: Below 10% year-over-year growthAction: Re-evaluate domestic herbicide and insecticide demand, specifically core brands like Impact and Aztec.
- International Sales PerformanceTrigger: Continued double-digit declines (e.g., Q1 2026 was down 7%)Action: Assess delivery timing in Brazil and India, and monitor drought conditions in Australia and channel inventories in Mexico.
- Debt and Leverage LevelsTrigger: Total debt exceeding $270 million or net debt rising above $200 millionAction: Review cash conversion, capital expenditure, and progress on the Centerbridge Partners term loan refinancing plan.
Research as of 19 Jun 2026